The Proprotein Convertases, 20 Years Later

Methods in Molecular Biology

Volumn 768, Issue , 2011, Pages 23-57

  Seidah, Nabil G ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

cancer metastasis; cholesterol metabolism; dyslipidemia; gene knockout; limited proteolysis; neural and endocrine disorders; Proprotein convertases; secretory proteins; single and pairs of basic residues; viral infections

Indexed keywords

PCSK9 PROTEIN, HUMAN; PCSK9 PROTEIN, MOUSE; PROTEINASE INHIBITOR; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; CHEMISTRY; CLASSIFICATION; DYSLIPIDEMIA; ENDOCRINE DISEASE; ENZYME SPECIFICITY; ENZYMOLOGY; HISTORY; HUMAN; METABOLISM; MOUSE; MOUSE MUTANT; NEOPLASM; PHYSIOLOGY; RAT; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; DYSLIPIDEMIAS; ENDOCRINE SYSTEM DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; MICE; MICE, KNOCKOUT; NEOPLASMS; PROPROTEIN CONVERTASES; PROTEASE INHIBITORS; RATS; SACCHAROMYCES CEREVISIAE; SEQUENCE HOMOLOGY; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY; VIRUS DISEASES;

BACTERIA (MICROORGANISMS); EUKARYOTA; MAMMALIA;

EID: 80054752024     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-204-5_3     Document Type: Chapter

References (222)

1. Gumbiner, B., and Kelly, R. B. (1982) Two distinct intracellular pathways transport secretory and membrane glycoproteins to the surface of pituitary tumor cells Cell 28, 51–9.
2. Julius, D., Brake, A., Blair, L., Kunisawa, R., and Thorner, J. (1984) Isolation of the putative structural gene for the lysine-arginine-cleaving endopeptidase required for processing of yeast prepro-alpha-factor Cell 37, 1075–89.
3. Fuller, R. S., Sterne, R. E., and Thorner, J. (1988) Enzymes required for yeast prohormone processing Annu Rev Physiol 50, 345–62.
4. Mizuno, K., Nakamura, T., Ohshima, T., Tanaka, S., and Matsuo, H. (1988) Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin-like serine proteases Biochem Biophys Res Commun 156, 246–54.
5. Seidah, N. G., Gaspar, L., Mion, P., Marcinkiewicz, M., Mbikay, M., and Chrétien, M. (1990) cDNA sequence of two distinct pituitary proteins homologous to Kex2 and furin gene products: Tissue-specific mRNAs encoding candidates for prohormone processing proteinases DNA Cell Biol 9, 789.
6. Thomas, G., Thorne, B. A., Thomas, L., Allen, R. G., Hruby, D. E., Fuller, R. et al. (1988) Yeast KEX2 endopeptidase correctly cleaves a neuroendocrine prohormone in mammalian cells Science 241, 226–30.
7. Bourbonnais, Y., Germain, D., Ash, J., and Thomas, D. Y. (1994) Cleavage of pro-somatostatins by the yeast Yap3 and Kex2 endoprotease Biochimie 76, 226–33.
8. Bathurst, I. C., Brennan, S. O., Carrell, R. W., Cousens, L. S., Brake, A. J., and Barr, P. J. (1987) Yeast KEX2 protease has the properties of a human proalbumin converting enzyme Science 235, 348–50.
9. Roebroek, A. J., Schalken, J. A., Bussemakers, M. J., van Heerikhuizen, H., Onnekink, C., Debruyne, F. M. et al. (1986) Characterization of human c-fes/fps reveals a new transcription unit (fur) in the immediately upstream region of the proto-oncogene Mol Biol Rep 11, 117–25.
10. van den Ouweland, A. M., Van Groningen, J. J., Roebroek, A. J., Onnekink, C., and Van de Ven, W. J. (1989) Nucleotide sequence analysis of the human fur gene Nucleic Acids Res 17, 7101–2.
11. Van de Ven, W. J., Voorberg, J., Fontijn, R., Pannekoek, H., van den Ouweland, A. M., van Duijnhoven, H. L. et al. (1990) Furin is a subtilisin-like proprotein processing enzyme in higher eukaryotes Mol Biol Rep 14, 265–75.
12. Nakayama, K. (1997) Furin: A mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins Biochem J 327(Pt 3), 625–35.
13. Steiner, D. F. (1998) The proprotein convertases Curr Opin Chem Biol 2, 31–9.
14. Seidah, N. G., and Chrétien, M. (1999) Proprotein and prohormone convertases: A family of subtilases generating diverse bioactive polypeptides Brain Res 848, 45–62.
15. Thomas, G. (2002) Furin at the cutting edge: From protein traffic to embryogenesis and disease Nat Rev Mol Cell Biol 3, 753–66.
16. Seidah, N. G., Mayer, G., Zaid, A., Rousselet, E., Nassoury, N., Poirier, S. et al. (2008) The activation and physiological functions of the proprotein convertases Int J Biochem Cell Biol 40, 1111–25.
17. Henrich, S., Cameron, A., Bourenkov, G. P., Kiefersauer, R., Huber, R., Lindberg, I. et al. (2003) The crystal structure of the proprotein processing proteinase furin explains its stringent specificity Nat Struct Biol 10, 520–6.
18. Benjannet, S., Rhainds, D., Hamelin, J., Nassoury, N., and Seidah, N. G. (2006) The proprotein convertase PCSK9 is inactivated by furin and/or PC5/6A: Functional consequences of natural mutations and post-translational modifications J Biol Chem 281, 30561–72.
19. Rawling, J., Garcia-Barreno, B., and Melero, J. A. (2008) Insertion of the two cleavage sites of the respiratory syncytial virus fusion protein in Sendai virus fusion protein leads to enhanced cell-cell fusion and a decreased dependency on the HN attachment protein for activity J Virol 82, 5986–98.
20. Groskreutz, D. J., Sliwkowski, M. X., and Gorman, C. M. (1994) Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin J Biol Chem 269, 6241–5.
21. Jin, W., Fuki, I. V., Seidah, N. G., Benjannet, S., Glick, J. M., and Rader, D. J. (2005) Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase J Biol Chem 280, 36551–9.
22. Roebroek, A. J., Umans, L., Pauli, I. G., Robertson, E. J., van Leuven, F., Van de Ven, W. J. et al. (1998) Failure of ventral closure and axial rotation in embryos lacking the proprotein convertase Furin Development 125, 4863–76.
23. Ducy, P., and Karsenty, G. (2000) The family of bone morphogenetic proteins Kidney Int 57, 2207–14.
24. Karsenty, G. (1999) The genetic transformation of bone biology Genes Dev 13, 3037–51.
25. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S., and Akhurst, R. J. (1995) Defective haematopoiesis and vas-culogenesis in transforming growth factor-beta 1 knock out mice Development 121, 1845–54.
26. Degnin, C., Jean, F., Thomas, G., and Christian, J. L. (2004) Cleavages within the prodomain direct intracellular trafficking and degradation of mature bone morphogenetic protein-4 Mol Biol Cell 15, 5012–20.
27. Dubois, C. M., Blanchette, F., Laprise, M. H., Leduc, R., Grondin, F., and Seidah, N. G. (2001) Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme Am J Pathol 158, 305–16.
28. Cui, Y., Jean, F., Thomas, G., and Christian, J. L. (1998) BMP-4 is proteolytically activated by furin and/or PC6 during vertebrate embryonic development EMBO J 17, 4735–43.
29. Roebroek, A. J., Taylor, N. A., Louagie, E., Pauli, I., Smeijers, L., Snellinx, A. et al. (2004) Limited redundancy of the proprotein convertase furin in mouse liver J Biol Chem 279, 53442–50.
30. Louagie, E., Taylor, N. A., Flamez, D., Roebroek, A. J., Bright, N. A., Meulemans, S. et al. (2008) Role of furin in granular acidification in the endocrine pancreas: Identification of the V-ATPase subunit Ac45 as a candidate substrate Proc Natl Acad Sci USA 105, 12319–24.
31. Pesu, M., Watford, W. T., Wei, L., Xu, L., Fuss, I., Strober, W. et al. (2008) T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance Nature 455, 246–50.
32. Jean, F., Thomas, L., Molloy, S. S., Liu, G., Jarvis, M. A., Nelson, J. A. et al. (2000) A protein-based therapeutic for human cytomegalovirus infection Proc Natl Acad Sci USA 97, 2864–9.
33. Komiyama, T., Coppola, J. M., Larsen, M. J., van Dort, M. E., Ross, B. D., Day, R. et al. (2009) Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules J Biol Chem 284, 15729–38.
34. Jiao, G. S., Cregar, L., Wang, J., Millis, S. Z., Tang, C., O‘Malley, S. et al. (2006) Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamine Proc Natl Acad Sci USA 103, 19707–12.
35. Coppola, J. M., Bhojani, M. S., Ross, B. D., and Rehemtulla, A. (2008) A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness Neoplasia 10, 363–70.
36. Bassi, D. E., Lopez, D. C., Mahloogi, H., Zucker, S., Thomas, G., and Klein-Szanto, A. J. (2001) Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells Proc Natl Acad Sci USA 98, 10326–31.
37. Khatib, A. M., Siegfried, G., Chrétien, M., Metrakos, P., and Seidah, N. G. (2002) Proprotein convertases in tumor progression and malignancy: Novel targets in cancer therapy Am J Pathol 160, 1921–35.
38. Shiryaev, S. A., Remacle, A. G., Ratnikov, B. I., Nelson, N. A., Savinov, A. Y., Wei, G. et al. (2007) Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens J Biol Chem 282, 20847–53.
39. Ozden, S., Lucas-Hourani, M., Ceccaldi, P. E., Basak, A., Valentine, M., Benjannet, S. et al. (2008) Inhibition of chikungunya virus infection in cultured human muscle cells by furin inhibitors: Impairment of the maturation of the E2 surface glycoprotein J Biol Chem 283, 21899–908.
40. Xiao, Y., Chen, G., Richard, J., Rougeau, N., Li, H., Seidah, N. G. et al. (2008) Cell-surface processing of extracellular human immunodeficiency virus type 1 Vpr by proprotein convertases Virology 372, 384–97.
41. Docherty, K., and Steiner, D. F. (1982) Post-translational proteolysis in polypeptide hormone biosynthesis Annu Rev Physiol 44, 625–38.
42. Loh, Y. P. (1987) Peptide precursor processing enzymes within secretory vesicles Ann N Y Acad Sci 493, 292–307.
43. Kuliawat, R., and Arvan, P. (1994) Distinct molecular mechanisms for protein sorting within immature secretory granules of pancreatic beta-cells J Cell Biol 126, 77–86.
44. Cromlish, J. A., Seidah, N. G., and Chrétien, M. (1986) Selective cleavage of human ACTH, beta-lipotropin, and the N-terminal glycopeptide at pairs of basic residues by IRCM-serine protease 1. Subcellular localization in small and large vesicles J Biol Chem 261, 10859–70.
45. Seidah, N. G., Paquin, J., Hamelin, J., Benjannet, S., and Chrétien, M. (1988) Structural and immunological homology of human and porcine pituitary and plasma IRCM-serine protease 1 to plasma kallikrein: Marked selectivity for pairs of basic residues suggests a widespread role in pro-hormone and pro-enzyme processing Biochimie 70, 33–46.
46. Metters, K. M., Rossier, J., Paquin, J., Chrétien, M., and Seidah, N. G. (1988) Selective cleavage of proenkephalin-derived peptides (less than 23,300 dal-tons) by plasma kallikrein J Biol Chem 263, 12543–53.
47. Davidson, H. W., Rhodes, C. J., and Hutton, J. C. (1988) Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases Nature 333, 93–6.
48. Mullis, K. B., and Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction Meth Enzymol 155, 335–50.
49. Hutchison, C. A., III, Phillips, S., Edgell, M. H., Gillam, S., Jahnke, P., and Smith, M. (1978) Mutagenesis at a specific position in a DNA sequence J Biol Chem 253, 6551–60.
50. Crine, P., Gianoulakis, C., Seidah, N. G., Gossard, F., Pezalla, P. D., Lis, M. et al. (1978) Biosynthesis of beta-endorphin from beta-lipotropin and a larger molecular weight precursor in rat pars intermedia Proc Natl Acad Sci USA 75, 4719–23.
51. Crine, P., Seidah, N. G., Routhier, R., Gossard, F., and Chrétien, M. (1980) Processing of two forms of the common precursor to alpha-melanotropin and beta-endorphin in the rat pars intermedia. Evidence for and partial characterization of new pituitary peptides Eur J Biochem 110, 387–96.
52. Crine, P., Gossard, F., Seidah, N. G., Blanchette, L., Lis, M., and Chrétien, M. (1979) Concomitant synthesis of beta-endorphin and alpha-melanotropin from two forms of pro-opiomelanocortin in the rat pars intermedia Proc Natl Acad Sci USA 76, 5085–9.
53. Seidah, N. G., Lazure, C., Chrétien, M., Thibault, G., Garcia, R., Cantin, M. et al. (1984) Amino acid sequence of homologous rat atrial peptides: Natriuretic activity of native and synthetic forms Proc Natl Acad Sci USA 81, 2640–4.
54. Yan, W., Sheng, N., Seto, M., Morser, J., and Wu, Q. (1999) Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart J Biol Chem 274, 14926–35.
55. Seidah, N. G., Marcinkiewicz, M., Benjannet, S., Gaspar, L., Beaubien, G., Mattei, M. G. et al. (1991) Cloning and primary sequence of a mouse candidate prohormone convertase PC1 homologous to PC2, Furin, and Kex2: Distinct chromosomal localization and messenger RNA distribution in brain and pituitary compared to PC2 Mol Endocrinol 5, 111–22.
56. Seidah, N. G., Mattei, M. G., Gaspar, L., Benjannet, S., Mbikay, M., and Chrétien, M. (1991) Chromosomal assignments of the genes for neuroendocrine convertase PC1 (NEC1) to human 5q15-21, neuroendocrine convertase PC2 (NEC2) to human 20p11.1-11.2, and furin (mouse 7[D1-E2] region) Genomics 11, 103–7.
57. Benjannet, S., Rondeau, N., Day, R., Chrétien, M., and Seidah, N. G. (1991) PC1 and PC2 are proprotein convertases capable of cleaving proopiomelanocortin at distinct pairs of basic residues Proc Natl Acad Sci USA 88, 3564–8.
58. Smeekens, S. P., and Steiner, D. F. (1990) Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2 J Biol Chem 265, 2997–3000.
59. Smeekens, S. P., Avruch, A. S., LaMendola, J., Chan, S. J., and Steiner, D. F. (1991) Identification of a cDNA encoding a second putative prohormone convertase related to PC2 in AtT20 cells and islets of Langerhans Proc Natl Acad Sci USA 88, 340–4.
60. Smeekens, S. P., Montag, A. G., Thomas, G., Albiges-Rizo, C., Carroll, R., Benig, M. et al. (1992) Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3 Proc Natl Acad Sci USA 89, 8822–6.
61. Thomas, L., Leduc, R., Thorne, B. A., Smeekens, S. P., Steiner, D. F., and Thomas, G. (1991) Kex2-like endoproteases PC2 and PC3 accurately cleave a model prohormone in mammalian cells: Evidence for a common core of neuroendocrine processing enzymes Proc Natl Acad Sci USA 88, 5297–301.
62. Malide, D., Seidah, N. G., Chrétien, M., and Bendayan, M. (1995) Electron microscopic immunocytochemical evidence for the involvement of the convertases PC1 and PC2 in the processing of proinsulin in pancreatic beta-cells J Histochem Cytochem 43, 11–19.
63. Dikeakos, J. D., Mercure, C., Lacombe, M. J., Seidah, N. G., and Reudelhuber, T. L. (2007) PC1/3, PC2 and PC5/6A are targeted to dense core secretory granules by a common mechanism FEBS J 274, 4094–102.
64. Dikeakos, J. D., Di, L. P., Lacombe, M. J., Ghirlando, R., Legault, P., Reudelhuber, T. L. et al. (2009) Functional and structural characterization of a dense core secretory granule sorting domain from the PC1/3 protease Proc Natl Acad Sci USA 106, 7408–13.
65. Fricker, L. D., McKinzie, A. A., Sun, J., Curran, E., Qian, Y., Yan, L. et al. (2000) Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing J Neurosci 20, 639–48.
66. Qian, Y., Devi, L. A., Mzhavia, N., Munzer, S., Seidah, N. G., and Fricker, L. D. (2000) The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1 J Biol Chem 275, 23596–601.
67. Feng, Y., Reznik, S. E., and Fricker, L. D. (2002) ProSAAS and prohormone convertase 1 are broadly expressed during mouse development Brain Res Gene Expr Patterns 1, 135–40.
68. Hsi, K. L., Seidah, N. G., Lu, C. L., and Chrétien, M. (1981) Reinvestigation of the N-terminal amino acid sequence of beta-lipotropin from human pituitary glands Biochem Biophys Res Commun 103, 1329–35.
69. Hsi, K. L., Seidah, N. G., De Serres, G., and Chrétien, M. (1982) Isolation and NH2-terminal sequence of a novel porcine anterior pituitary polypeptide. Homology to proinsulin, secretin and Rous sarcoma virus transforming protein TVFV60 FEBS Lett 147, 261–6.
70. Seidah, N. G., Hsi, K. L., De Serres, G., Rochemont, J., Hamelin, J., Antakly, T. et al. (1983) Isolation and NH2-terminal sequence of a highly conserved human and porcine pituitary protein belonging to a new superfamily. Immunocytochemical localization in pars distalis and pars nervosa of the pituitary and in the supraoptic nucleus of the hypothalamus Arch Biochem Biophys 225, 525–34.
71. Marcinkiewicz, M., Benjannet, S., Cantin, M., Seidah, N. G., and Chrétien, M. (1986) CNS distribution of a novel pituitary protein ‘7B2’: Localization in secretory and synaptic vesicles Brain Res 380, 349–56.
72. Marcinkiewicz, M., Benjannet, S., Seidah, N. G., Cantin, M., and Chrétien, M. (1985) Immunocytochemical localization of a novel pituitary protein (7B2) within the rat brain and hypophysis J Histochem Cytochem 33, 1219–26.
73. Mbikay, M., Seidah, N. G., and Chrétien, M. (2001) Neuroendocrine secretory protein 7B2: Structure, expression and functions Biochem J 357, 329–42.
74. Martens, G. J., Braks, J. A., Eib, D. W., Zhou, Y., and Lindberg, I. (1994) The neuroendocrine polypeptide 7B2 is an endogenous inhibitor of prohormone convertase PC2 Proc Natl Acad Sci USA 91, 5784–7.
75. van Horssen, A. M., van den Hurk, W. H., Bailyes, E. M., Hutton, J. C., Martens, G. J., and Lindberg, I. (1995) Identification of the region within the neuroendocrine polypeptide 7B2 responsible for the inhibition of prohormone convertase PC2 J Biol Chem 270, 14292–6.
76. Zhu, X., and Lindberg, I. (1995) 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity J Cell Biol 129, 1641–50.
77. Benjannet, S., Savaria, D., Chrétien, M., and Seidah, N. G. (1995) 7B2 is a specific intracellular binding protein of the prohormone convertase PC2 J Neurochem 64, 2303–11.
78. Benjannet, S., Mamarbachi, A. M., Hamelin, J., Savaria, D., Munzer, J. S., Chrétien, M. et al. (1998) Residues unique to the pro-hormone convertase PC2 modulate its autoactivation, binding to 7B2 and enzymatic activity FEBS Lett 428, 37–42.
79. Paquet, L., Bergeron, F., Boudreault, A., Seidah, N. G., Chrétien, M., Mbikay, M. et al. (1994) The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase J Biol Chem 269, 19279–85.
80. Fortenberry, Y., Liu, J., and Lindberg, I. (1999) The role of the 7B2 CT peptide in the inhibition of prohormone convertase 2 in endocrine cell lines J Neurochem 73, 994–1003.
81. Zhu, X., Zhou, A., Dey, A., Norrbom, C., Carroll, R., Zhang, C. et al. (2002) Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects Proc Natl Acad Sci USA 99, 10293–8.
82. Furuta, M., Yano, H., Zhou, A., Rouille, Y., Holst, J. J., Carroll, R. et al. (1997) Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2 Proc Natl Acad Sci USA 94, 6646–51.
83. Jackson, R. S., Creemers, J. W., Ohagi, S., Raffin-Sanson, M. L., Sanders, L., Montague, C. T. et al. (1997) Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene Nat Genet 16, 303–6.
84. Jackson, R. S., Creemers, J. W., Farooqi, I. S., Raffin-Sanson, M. L., Varro, A., Dockray, G. J. et al. (2003) Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency J Clin Invest 112, 1550–60.
85. Croissandeau, G., Wahnon, F., Yashpal, K., Seidah, N. G., Coderre, T. J., Chrétien, M. et al. (2006) Increased stress-induced analgesia in mice lacking the proneuropeptide convertase PC2 Neurosci Lett 406, 71–5.
86. Lloyd, D. J., Bohan, S., and Gekakis, N. (2006) Obesity, hyperphagia and increased metabolic efficiency in Pc1 mutant mice Hum Mol Genet 15, 1884–93.
87. Benzinou, M., Creemers, J. W., Choquet, H., Lobbens, S., Dina, C., Durand, E. et al. (2008) Common nonsynonymous variants in PCSK1 confer risk of obesity Nat Genet 40, 943–5.
88. Wardman, J. H., Zhang, X., Gagnon, S., Castro, L. M., Zhu, X., Steiner, D. F. et al. (2010) Analysis of peptides in prohormone convertase 1/3 null mouse brain using quantitative peptidomics J Neurochem 114, 215–25.
89. Zhang, X., Pan, H., Peng, B., Steiner, D. F., Pintar, J. E., and Fricker, L. D. (2010) Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesis J Neurochem 112, 1168–79.
90. Morgan, D. J., Wei, S., Gomes, I., Czyzyk, T., Mzhavia, N., Pan, H. et al. (2010) The propeptide precursor proSAAS is involved in fetal neuropeptide processing and body weight regulation J Neurochem 113, 1275–84.
91. Westphal, C. H., Muller, L., Zhou, A., Zhu, X., Bonner-Weir, S., Schambelan, M. et al. (1999) The neuroendocrine protein 7B2 is required for peptide hormone processing in vivo and provides a novel mechanism for pituitary Cushing’s disease Cell 96, 689–700.
92. Lee, S. N., Peng, B., Desjardins, R., Pintar, J. E., Day, R., and Lindberg, I. (2007) Strain-specific steroidal control of pituitary function J Endocrinol 192, 515–25.
93. Kiefer, M. C., Tucker, J. E., Joh, R., Landsberg, K. E., Saltman, D., and Barr, P. J. (1991) Identification of a second human subtilisin-like protease gene in the fes/fps region of chromosome 15 DNA Cell Biol 10, 757–69.
94. Seidah, N. G., Day, R., Hamelin, J., Gaspar, A., Collard, M. W., and Chrétien, M. (1992) Testicular expression of PC4 in the rat: Molecular diversity of a novel germ cell-specific Kex2/subtilisin-like proprotein convertase Mol Endocrinol 6, 1559–70.
95. Lusson, J., Vieau, D., Hamelin, J., Day, R., Chrétien, M., and Seidah, N. G. (1993) cDNA structure of the mouse and rat subtilisin/kexin-like PC5: A candidate proprotein convertase expressed in endocrine and nonendocrine cells Proc Natl Acad Sci USA 90, 6691–5.
96. Gyamera-Acheampong, C., Tantibhed-hyangkul, J., Weerachatyanukul, W., Tadros, H., Xu, H., Van de Loo, J. W. et al. (2006) Sperm from mice genetically deficient for the PCSK4 proteinase exhibit accelerated capacitation, precocious acrosome reaction, reduced binding to egg zona pellucida, and impaired fertilizing ability Biol Reprod 74, 666–73.
97. Tadros, H., Chrétien, M., and Mbikay, M. (2001) The testicular germ-cell protease PC4 is also expressed in macrophage-like cells of the ovary J Reprod Immunol 49, 133–52.
98. Qiu, Q., Basak, A., Mbikay, M., Tsang, B. K., and Gruslin, A. (2005) Role of pro-IGF-II processing by proprotein convertase 4 in human placental development Proc Natl Acad Sci USA 102, 11047–52.
99. Mbikay, M., Tadros, H., Ishida, N., Lerner, C. P., De Lamirande, E., Chen, A. et al. (1997) Impaired fertility in mice deficient for the testicular germ-cell protease PC4 Proc Natl Acad Sci USA 94, 6842–6.
100. Li, M., Mbikay, M., and Arimura, A. (2000) Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads Endocrinology 141, 3723–30.
101. Basak, S., Chrétien, M., Mbikay, M., and Basak, A. (2004) In vitro elucidation of substrate specificity and bioassay of proprotein convertase 4 using intramolecularly quenched fluorogenic peptides Biochem J 380, 505–14.
102. Majumdar, S., Mohanta, B. C., Chowdhury, D. R., Banik, R., Dinda, B., and Basak, A. (2010) Proprotein convertase inhibitory activities of flavonoids isolated from oroxy-lum indicum Curr Med Chem 17, 2049–58.
103. Nakagawa, T., Hosaka, M., Torii, S., Watanabe, T., Murakami, K., and Nakayama, K. (1993) Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: Its striking structural similarity to PACE4 J Biochem (Tokyo) 113, 132–5.
104. Nakagawa, T., Murakami, K., and Nakayama, K. (1993) Identification of an isoform with an extremely large Cys-rich region of PC6, a Kex2-like processing endoprotease FEBS Lett 327, 165–71.
105. Nour, N., Mayer, G., Mort, J. S., Salvas, A., Mbikay, M., Morrison, C. J. et al. (2005) The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases Mol Biol Cell 16, 5215–26.
106. Mayer, G., Hamelin, J., Asselin, M. C., Pasquato, A., Marcinkiewicz, E., Tang, M. et al. (2008) The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates J Biol Chem 283, 2373–84.
107. Kalus, I., Schnegelsberg, B., Seidah, N. G., Kleene, R., and Schachner, M. (2003) The proprotein convertase PC5A and a metallo-protease are involved in the proteolytic processing of the neural adhesion molecule L1 J Biol Chem 278, 10381–8.
108. Seidah, N. G., and Prat, A. (2002) Precursor convertases in the secretory pathway, cytosol and extracellular milieu Essays Biochem 38, 79–94.
109. Xiang, Y., Molloy, S. S., Thomas, L., and Thomas, G. (2000) The PC6B cytoplasmic domain contains two acidic clusters that direct sorting to distinct trans-Golgi network/endosomal compartments Mol Biol Cell 11, 1257–73.
110. Dong, W., Marcinkiewicz, M., Vieau, D., Chrétien, M., Seidah, N. G., and Day, R. (1995) Distinct mRNA expression of the highly homologous convertases PC5 and PACE4 in the rat brain and pituitary J Neurosci 15, 1778–96.
111. Zheng, M., Seidah, N. G., and Pintar, J. E. (1997) The developmental expression in the rat CNS and peripheral tissues of proteases PC5 and PACE4 mRNAs: Comparison with other proprotein processing enzymes Dev Biol 181, 268–83.
112. Essalmani, R., Hamelin, J., Marcinkiewicz, J., Chamberland, A., Mbikay, M., Chrétien, M. et al. (2006) Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouse Mol Cell Biol 26, 354–61.
113. Constam, D. B., and Robertson, E. J. (2000) SPC4/PACE4 regulates a TGFbeta signaling network during axis formation Genes Dev 14, 1146–55.
114. Essalmani, R., Zaid, A., Marcinkiewicz, J., Chamberland, A., Pasquato, A., Seidah, N. G. et al. (2008) In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate Proc Natl Acad Sci USA 105, 5750–5.
115. Szumska, D., Pieles, G., Essalmani, R., Bilski, M., Mesnard, D., Kaur, K. et al. (2008) VACTERL/caudal regression/Currarino syndrome-like malformations in mice with mutation in the proprotein convertase Pcsk5 Genes Dev 22, 1465–77.
116. Sun, X., Essalmani, R., Seidah, N. G., and Prat, A. (2009) The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: In vivo mouse model Mol Cancer 8, 73.
117. Yuasa, K., Masuda, T., Yoshikawa, C., Nagahama, M., Matsuda, Y., and Tsuji, A. (2009) Subtilisin-like proprotein convertase PACE4 is required for skeletal muscle differentiation J Biochem (Tokyo) 146, 407–15.
118. Blanchet, M. H., Le Good, J. A., Mesnard, D., Oorschot, V., Baflast, S., Min-chiotti, G. et al. (2008) Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation EMBO J 27, 2580–91.
119. Seidah, N. G., Hamelin, J., Mamarbachi, M., Dong, W., Tardos, H., Mbikay, M. et al. (1996) cDNA structure, tissue distribution, and chromosomal localization of rat PC7, a novel mammalian proprotein convertase closest to yeast kexin-like proteinases Proc Natl Acad Sci USA 93, 3388–93.
120. Meerabux, J., Yaspo, M. L., Roebroek, A. J., Van de Ven, W. J., Lister, T. A., and Young, B. D. (1996) A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas Cancer Res 56, 448–51.
121. Van de Loo, J. W., Teuchert, M., Pauli, I., Plets, E., Van de Ven, W. J., and Creemers, J. W. (2000) Dynamic palmitoylation of lymphoma proprotein convertase prolongs its half-life, but is not essential for trans-Golgi network localization Biochem J 352(Pt 3), 827–33.
122. Munzer, J. S., Basak, A., Zhong, M., Mamarbachi, A., Hamelin, J., Savaria, D. et al. (1997) In vitro characterization of the novel proprotein convertase PC7 J Biol Chem 272, 19672–81.
123. Seidah, N. G. (2004) Proprotein Convertase 7. In: Handbook of Proteolytic Enzymes, 2nd Edition. Barrett, A. J., Rawlings, N. D. and Woessner, J. F., eds., Academic: San Diego, CA, pp. 1877–80.
124. Basak, A., Zhong, M., Munzer, J. S., Chrétien, M., and Seidah, N. G. (2001) Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: A comparative analysis with fluorogenic peptides Biochem J 353, 537–45.
125. Fugere, M., Appel, J., Houghten, R. A., Lindberg, I., and Day, R. (2007) Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences Mol Pharmacol 71, 323–32.
126. Decroly, E., Benjannet, S., Savaria, D., and Seidah, N. G. (1997) Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160 FEBS Lett 405, 68–72.
127. Lopez-Perez, E., Seidah, N. G., and Checler, F. (1999) Proprotein convertase activity contributes to the processing of the Alzheimer’s beta-amyloid precursor protein in human cells: Evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway J Neurochem 73, 2056–62.
128. Scamuffa, N., Basak, A., Lalou, C., Wargnier, A., Marcinkiewicz, J., Siegfried, G. et al. (2008) Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7 Gut 57, 1573–82.
129. Siegfried, G., Basak, A., Cromlish, J. A., Benjannet, S., Marcinkiewicz, J., Chrétien, M. et al. (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis J Clin Invest 111, 1723–32.
130. Van de Loo, J. W., Creemers, J. W., Bright, N. A., Young, B. D., Roebroek, A. J., and Van de Ven, W. J. (1997) Biosynthesis, distinct post-translational modifications, and functional characterization of lymphoma proprotein convertase J Biol Chem 272, 27116–23.
131. Wouters, S., Decroly, E., Vandenbranden, M., Shober, D., Fuchs, R., Morel, V. et al. (1999) Occurrence of an HIV-1 gp160 endoproteolytic activity in low-density vesicles and evidence for a distinct density distribution from endogenously expressed furin and PC7/LPC convertases FEBS Lett 456, 97–102.
132. Zhong, M., Munzer, J. S., Basak, A., Benjannet, S., Mowla, S. J., Decroly, E. et al. (1999) The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity J Biol Chem 274, 33913–20.
133. Nour, N., Basak, A., Chrétien, M., and Seidah, N. G. (2003) Structure-function analysis of the prosegment of the proprotein convertase PC5A J Biol Chem 278, 2886–95.
134. Bhattacharjya, S., Xu, P., Zhong, M., Chrétien, M., Seidah, N. G., and Ni, F. (2000) Inhibitory activity and structural characterization of a C-terminal peptide fragment derived from the prosegment of the proprotein convertase PC7 Biochemistry 39, 2868–77.
135. Leonhardt, R. M., Fiegl, D., Rufer, E., Karger, A., Bettin, B., and Knittler, M. R. (2010) Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7 J Immunol 184, 2985–98.
136. Bassi, D. E., Fu, J., Lopez, D. C., and Klein-Szanto, A. J. (2005) Proprotein convertases: “Master switches” in the regulation of tumor growth and progression Mol Carcinog 44, 151–61.
137. Seidah, N. G., Mowla, S. J., Hamelin, J., Mamarbachi, A. M., Benjannet, S., Toure, B. B. et al. (1999) Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization Proc Natl Acad Sci USA 96, 1321–6.
138. Haze, K., Yoshida, H., Yanagi, H., Yura, T., and Mori, K. (1999) Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress Mol Biol Cell 10, 3787–99.
139. Cheng, D., Espenshade, P. J., Slaughter, C. A., Jaen, J. C., Brown, M. S., and Goldstein, J. L. (1999) Secreted site-1 protease cleaves peptides corresponding to luminal loop of sterol regulatory element-binding proteins J Biol Chem 274, 22805–12.
140. Horton, J. D., Goldstein, J. L., and Brown, M. S. (2002) SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver J Clin Invest 109, 1125–31.
141. Elagoz, A., Benjannet, S., Mammarbassi, A., Wickham, L., and Seidah, N. G. (2002) Biosynthesis and cellular trafficking of the convertase SKI-1/S1P: Ectodomain shedding requires SKI-1 activity J Biol Chem 277, 11265–75.
142. Tadros, H., Seidah, N. G., Chrétien, M., and Mbikay, M. (2002) Genetic mapping of the gene for SKI-1/S1P protease (locus symbol Mbtps1) to mouse chromosome 8 DNA Seq 13, 109–11.
143. Pasquato, A., Pullikotil, P., Asselin, M. C., Vacatello, M., Paolillo, L., Ghezzo, F. et al. (2006) The Proprotein Convertase SKI-1/S1P: In vitro analysis of lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors J Biol Chem 281, 23471–81.
144. Sakai, J., Rawson, R. B., Espenshade, P. J., Cheng, D., Seegmiller, A. C., Goldstein, J. L. et al. (1998) Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells Mol Cell 2, 505–14.
145. Brown, M. S., and Goldstein, J. L. (1997) The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89, 331–40.
146. Lenz, O., ter Meulen, J., Klenk, H. D., Seidah, N. G., and Garten, W. (2001) The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P Proc Natl Acad Sci USA 98, 12701–5.
147. Ye, J., Rawson, R. B., Komuro, R., Chen, X., Dave, U. P., Prywes, R. et al. (2000) ER stress induces cleavage of membrane-bound ATF6 by the same proteases that process SREBPs Mol Biol Cell 6, 1355–64.
148. Yang, J., Goldstein, J. L., Hammer, R. E., Moon, Y. A., Brown, M. S., and Horton, J. D. (2001) Decreased lipid synthesis in livers of mice with disrupted Site-1 protease gene Proc Natl Acad Sci USA 98, 13607–12.
149. Mouchantaf, R., Watt, H. L., Sulea, T., Seidah, N. G., Alturaihi, H., Patel, Y. C. et al. (2004) Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1 Regul Pept 120, 133–40.
150. Lu, R., Yang, P., O‘Hare, P., and Misra, V. (1997) Luman, a new member of the CREB/ATF family, binds to herpes simplex virus VP16-associated host cellular factor Mol Cell Biol 17, 5117–26.
151. Stirling, J., and O‘Hare, P. (2006) CREB4, a transmembrane bZip transcription factor and potential new substrate for regulation and cleavage by S1P Mol Biol Cell 17, 413–26.
152. Pullikotil, P., Vincent, M., Nichol, S. T., and Seidah, N. G. (2004) Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: Processing of SREBP-2, ATF6, and a viral glycoprotein J Biol Chem 279, 17338–47.
153. Basak, A., Chrétien, M., and Seidah, N. G. (2002) A rapid fluorometric assay for the proteolytic activity of SKI-1/S1P based on the surface glycoprotein of the hemorrhagic fever Lassa virus FEBS Lett 514, 333–9.
154. Toure, B. B., Munzer, J. S., Basak, A., Benjannet, S., Rochemont, J., Lazure, C. et al. (2000) Biosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegment J Biol Chem 275, 2349–58.
155. Okada, T., Haze, K., Nadanaka, S., Yoshida, H., Seidah, N. G., Hirano, Y. et al. (2003) A serine protease inhibitor prevents endoplasmic reticulum stress-induced cleavage but not transport of the membrane-bound transcription factor ATF6 J Biol Chem 278, 31024–32.
156. De Windt, A., Rai, M., Bernier, L., The-len, K., Soini, J., Lefebvre, C. et al. (2007) Gene set enrichment analysis reveals several globally affected pathways due to SKI-1/S1P inhibition in HepG2 cells DNA Cell Biol 26, 765–72.
157. Hawkins, J. L., Robbins, M. D., Warren, L. C., Xia, D., Petras, S. F., Valentine, J. J. et al. (2008) Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals J Pharmacol Exp Ther 326, 801–8.
158. Hay, B. A., Abrams, B., Zumbrunn, A. Y., Valentine, J. J., Warren, L. C., Petras, S. F. et al. (2007) Aminopyrrolidineamide inhibitors of site-1 protease Bioorg Med Chem Lett 17, 4411–14.
159. Gorski, J. P., Huffman, N. T., Cui, C., Henderson, E. P., Midura, R. J., and Seidah, N. G. (2009) Potential role of proprotein convertase SKI-1 in the mineralization of primary bone Cell Tissue Organ 189, 25–32.
160. Beyer, W. R., Popplau, D., Garten, W., Von Laer, D., and Lenz, O. (2003) Endoproteolytic processing of the lymphocytic chori-omeningitis virus glycoprotein by the subtilase SKI-1/S1P J Virol 77, 2866–72.
161. Vincent, M. J., Sanchez, A. J., Erickson, B. R., Basak, A., Chrétien, M., Seidah, N. G. et al. (2003) Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1 J Virol 77, 8640–9.
162. Mitchell, K. J., Pinson, K. I., Kelly, O. G., Brennan, J., Zupicich, J., Scherz, P. et al. (2001) Functional analysis of secreted and transmembrane proteins critical to mouse development Nat Genet 28, 241–9.
163. Patra, D., Xing, X., Davies, S., Bryan, J., Franz, C., Hunziker, E. B. et al. (2007) Site-1 protease is essential for endochondral bone formation in mice J Cell Biol 179, 687–700.
164. Brown, M. S., and Goldstein, J. L. (1974) Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity Proc Natl Acad Sci USA 71, 788–92.
165. Maxfield, F. R., and Tabas, I. (2005) Role of cholesterol and lipid organization in disease Nature 438, 612–21.
166. Briel, M., Nordmann, A. J., and Bucher, H. C. (2005) Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: Update on recent trials and meta-analyses Curr Opin Lipidol 16, 601–5.
167. Brown, M. S., and Goldstein, J. L. (2006) Biomedicine. Lowering LDL – not only how low, but how long? Science 311, 1721–3.
168. Tall, A. R. (2006) Protease variants, LDL, and coronary heart disease New Engl J Med 354, 1310–12.
169. Seidah, N. G., Benjannet, S., Wickham, L., Marcinkiewicz, J., Jasmin, S. B., Stifani, S. et al. (2003) The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation Proc Natl Acad Sci USA 100, 928–33.
170. Abifadel, M., Varret, M., Rabes, J. P., Allard, D., Ouguerram, K., Devillers, M. et al. (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat Genet 34, 154–6.
171. Seidah, N. G., and Prat, A. (2007) The proprotein convertases are potential targets in the treatment of dyslipidemia J Mol Med 85, 685–96.
172. Cohen, J., Pertsemlidis, A., Kotowski, I. K., Graham, R., Garcia, C. K., and Hobbs, H. H. (2005) Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9 Nat Genet 37, 161–5.
173. Kotowski, I. K., Pertsemlidis, A., Luke, A., Cooper, R. S., Vega, G. L., Cohen, J. C. et al. (2006) A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol Am J Hum Genet 78, 410–22.
174. Sirois, F., Gbeha, E., Sanni, A., Chrétien, M., Labuda, D., and Mbikay, M. (2008) Ethnic differences in the frequency of the cardio-protective C679X PCSK9 mutation in a West African population Genet Test 12, 377–80.
175. Leren, T. P. (2004) Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia Clin Genet 65, 419–22.
176. Timms, K. M., Wagner, S., Samuels, M. E., Forbey, K., Goldfine, H., Jammulap-ati, S. et al. (2004) A mutation in PCSK9 causing autosomal-dominant hypercholesterolemia in a Utah pedigree Hum Genet 114, 349–53.
177. Allard, D., Amsellem, S., Abifadel, M., Trillard, M., Devillers, M., Luc, G. et al. (2005) Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia Hum Mutat 26, 497–506.
178. Naoumova, R. P., Tosi, I., Patel, D., Neuwirth, C., Horswell, S. D., Marais, A. D. et al. (2005) Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: Long-term follow-up and treatment response Arterioscler Thromb Vasc Biol 25, 2654–60.
179. Berge, K. E., Ose, L., and Leren, T. P. (2006) Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy Arterioscler Thromb Vasc Biol 26, 1094–100.
180. Zhao, Z., Tuakli-Wosornu, Y., Lagace, T. A., Kinch, L., Grishin, N. V., Horton, J. D. et al. (2006) Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote Am J Hum Genet 79, 514–23.
181. Hooper, A. J., Marais, A. D., Tanyanyiwa, D. M., and Burnett, J. R. (2007) The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population Atherosclerosis 193, 445–8.
182. Rashid, S., Curtis, D. E., Garuti, R., Anderson, N. N., Bashmakov, Y., Ho, Y. K. et al. (2005) Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9 Proc Natl Acad Sci USA 102, 5374–9.
183. Zaid, A., Roubtsova, A., Essalmani, R., Marcinkiewicz, J., Chamberland, A., Hamelin, J. et al. (2008) Proprotein convertase subtilisin/kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration Hepatology 48, 646–54.
184. Maxwell, K. N., and Breslow, J. L. (2004) Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype Proc Natl Acad Sci USA 101, 7100–5.
185. Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W. et al. (2004) NARC-1/PCSK9 and its natural mutants: Zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol J Biol Chem 279, 48865–75.
186. Park, S. W., Moon, Y. A., and Horton, J. D. (2004) Post-transcriptional regulation of low density lipoprotein receptor protein by proprotein convertase subtilisin/kexin type 9a in mouse liver J Biol Chem 279, 50630–8.
187. Maxwell, K. N., Fisher, E. A., and Breslow, J. L. (2005) Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment Proc Natl Acad Sci USA 102, 2069–74.
188. Nassoury, N., Blasiole, D. A., Tebon, O. A., Benjannet, S., Hamelin, J., Poupon, V. et al. (2007) The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR Traffic 8, 718–32.
189. Dubuc, G., Chamberland, A., Wassef, H., Davignon, J., Seidah, N. G., Bernier, L. et al. (2004) Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia Arterioscler Thromb Vasc Biol 24, 1454–9.
190. Attie, A. D., and Seidah, N. G. (2005) Dual regulation of the LDL receptor – some clarity and new questions Cell Metab 1, 290–2.
191. McNutt, M. C., Lagace, T. A., and Horton, J. D. (2007) Catalytic activity is not required for secreted PCSK9 to reduce low density lipoprotein receptors in HepG2 cells J Biol Chem 282, 20799–803.
192. Li, J., Tumanut, C., Gavigan, J. A., Huang, W. J., Hampton, E. N., Tumanut, R. et al. (2007) Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity Biochem J 406, 203–7.
193. Dubuc, G., Tremblay, M., Pare, G., Jacques, H., Hamelin, J., Benjannet, S. et al. (2010) A new method for measurement of total plasma PCSK9: Clinical applications J Lipid Res 51, 140–9.
194. Cameron, J., Holla, O. L., Laerdahl, J. K., Kulseth, M. A., Ranheim, T., Rognes, T. et al. (2008) Characterization of novel mutations in the catalytic domain of the PCSK9 gene J Intern Med 263, 420–31.
195. Mayne, J., Raymond, A., Chaplin, A., Cousins, M., Kaefer, N., Gyamera-Acheampong, C. et al. (2007) Plasma PCSK9 levels correlate with cholesterol in men but not in women Biochem Biophys Res Commun 361, 451–6.
196. Lagace, T. A., Curtis, D. E., Garuti, R., McNutt, M. C., Park, S. W., Prather, H. B. et al. (2006) Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice J Clin Invest 116, 2995–3005.
197. Cunningham, D., Danley, D. E., Geoghegan, K. F., Griffor, M. C., Hawkins, J. L., Subashi, T. A. et al. (2007) Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia Nat Struct Biol 14, 413–19.
198. Hampton, E. N., Knuth, M. W., Li, J., Harris, J. L., Lesley, S. A., and Spraggon, G. (2007) The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain Proc Natl Acad Sci USA 104, 14604–9.
199. Piper, D. E., Jackson, S., Liu, Q., Romanow, W. G., Shetterly, S., Thibault, S. T. et al. (2007) The crystal structure of PCSK9: A regulator of plasma LDL-cholesterol Structure 15, 545–52.
200. Zhang, D. W., Lagace, T. A., Garuti, R., Zhao, Z., McDonald, M., Horton, J. D. et al. (2007) Binding of proprotein convertase subtilisin/kexin type 9 to epidermal growth factor-like repeat a of low density lipoprotein receptor decreases receptor recycling and increases degradation J Biol Chem 282, 18602–12.
201. Kwon, H. J., Lagace, T. A., McNutt, M. C., Horton, J. D., and Deisenhofer, J. (2008) Molecular basis for LDL receptor recognition by PCSK9 Proc Natl Acad Sci USA 105, 1820–5.
202. Dewpura, T., Raymond, A., Hamelin, J., Seidah, N. G., Mbikay, M., Chrétien, M. et al. (2008) PCSK9 is phosphorylated by a Golgi casein kinase-like kinase ex vivo and circulates as a phosphoprotein in humans FEBS J 275, 3480–93.
203. Poirier, S., Mayer, G., Benjannet, S., Bergeron, E., Marcinkiewicz, J., Nassoury, N. et al. (2008) The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2 J Biol Chem 283, 2363–72.
204. Labonte, P., Begley, S., Guevin, C., Asselin, M. C., Nassoury, N., Mayer, G. et al. (2009) PCSK9 impedes hepatitis C virus infection in vitro and modulates liver CD81 expression Hepatology 50, 17–24.
205. Cameron, J., Holla, O. L., Ranheim, T., Kulseth, M. A., Berge, K. E., and Leren, T. P. (2006) Effect of mutations in the PCSK9 gene on the cell surface LDL receptors Hum Mol Genet 15, 1551–8.
206. Conesa, M., Prat, A., Mort, J. S., Marvaldi, J., Lissitzky, J. C., and Seidah, N. G. (2003) Down-regulation of alphav/beta3 integrin via misrouting to lysosomes by overexpression of a beta3Lamp1 fusion protein Biochem J 370, 703–11.
207. Zhang, D. W., Garuti, R., Tang, W. J., Cohen, J. C., and Hobbs, H. H. (2008) Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor Proc Natl Acad Sci USA 105, 13045–50.
208. Qian, Y. W., Schmidt, R. J., Zhang, Y., Chu, S., Lin, A., Wang, H. et al. (2007) Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis J Lipid Res 48, 1488–98.
209. Chan, J. C., Piper, D. E., Cao, Q., Liu, D., King, C., Wang, W. et al. (2009) A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates Proc Natl Acad Sci USA 106, 9820–5.
210. Poirier, S., Mayer, G., Poupon, V., McPherson, P. S., Desjardins, R., Ly, K. et al. (2009) Dissection of the endogenous cellular pathways of PCSK9-induced LDLR degradation: Evidence for an intracellular route J Biol Chem 284, 28856–64.
211. Poupon, V., Girard, M., Legendre-Guillemin, V., Thomas, S., Bourbonniere, L., Philie, J. et al. (2008) Clathrin light chains function in mannose phosphate receptor trafficking via regulation of actin assembly Proc Natl Acad Sci USA 105, 168–73.
212. Mayer, G., Poirier, S., and Seidah, N. G. (2008) Annexin A2 is a C-terminal PCSK9-binding protein that regulates endogenous low density lipoprotein receptor levels J Biol Chem 283, 31791–801.
213. Cesarman, G. M., Guevara, C. A., and Haj-jar, K. A. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA) II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation J Biol Chem 269, 21198–203.
214. Ma, A. S., Bell, D. J., Mittal, A. A., and Harrison, H. H. (1994) Immunocytochemical detection of extracellular annexin II in cultured human skin keratinocytes and isolation of annexin II isoforms enriched in the extracellular pool J Cell Sci 107(Pt 7), 1973–84.
215. Chung, C. Y., and Erickson, H. P. (1994) Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C J Cell Biol 126, 539–48.
216. Patchell, B. J., Wojcik, K. R., Yang, T. L., White, S. R., and Dorscheid, D. R. (2007) Glycosylation and annexin II cell surface translocation mediate airway epithelial wound repair Am J Physiol Lung Cell Mol Physiol 293, L354–63.
217. Yeatman, T. J., Updyke, T. V., Kaetzel, M. A., Dedman, J. R., and Nicolson, G. L. (1993) Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells Clin Exp Metastasis 11, 37–44.
218. Luo, Y., Warren, L., Xia, D., Jensen, H., Sand, T., Petras, S. et al. (2008) Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice J Lipid Res 50, 1581–8.
219. Dietschy, J. M., Turley, S. D., and Spady, D. K. (1993) Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans J Lipid Res 34, 1637–59.
220. Alborn, W. E., Cao, G., Careskey, H. E., Qian, Y. W., Subramaniam, D. R., Davies, J. et al. (2007) Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol Clin Chem 53, 1814–19.
221. Grefhorst, A., McNutt, M. C., Lagace, T. A., and Horton, J. D. (2008) Plasma PCSK9 preferentially reduces liver LDL receptors in mice J Lipid Res 49, 1303–11.
222. Mbikay, M., Sirois, F., Mayne, J., Wang, G. S., Chen, A., Dewpura, T. et al. (2010) PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities FEBS Lett 584, 701–6.